Hinge Health Earnings & Forecasts

Hinge Health (HNGE) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Aug 4, 2026	$0.59	$0.55	7.27 %
Q1	May 5, 2026	$0.45	$0.34	32.4 %
Q4	Feb 10, 2026	$0.49	$0.27	81.5 %
Q3	Nov 4, 2025	$-0.02	$-0.15	86.7 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Aug 4, 2026	$212.82M	$201.11M	5.82 %
Q1	May 5, 2026	$182.31M	$172.24M	5.85 %
Q4	Feb 10, 2026	$170.73M	$156.97M	8.76 %
Q3	Nov 4, 2025	$154.21M	$142.25M	8.41 %

Hinge Health Guidance

Hinge Health (HNGE)는 8월 4, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $856M - $860M 범위로 예상했습니다.

이전 가이던스와 비교하여 Hinge Health는 매출 전망치를 이전 범위인 상향 조정됨에서 $818M - $824M로 상향 조정했습니다.

Hinge Health은 12과 8월 5, 2025 사이에 8월 4, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 7 times and lowered it 4 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.55	$0.34	$0.27	$-0.15
Actual	$0.59	$0.45	$0.49	$-0.02
Surprise	+7.27%	+32.4%	+81.5%	+86.7%
Revenue
Estimate	$201.1M	$172.2M	$157.0M	$142.2M
Actual	$212.8M	$182.3M	$170.7M	$154.2M
Surprise	+5.82%	+5.85%	+8.76%	+8.41%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.55	$0.61	$0.25	$0.34
Revenue
Consensus	$224.8M	$239.1M	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Hinge Health Raises FY2026 Sales Guidance from $818.000M-$824.000M to $856.000M-$860.000M vs $822.049M Est

Hinge Health (NYSE:HNGE) raises FY2026 sales outlook from $818.000 million-$824.000 million to $856.000 million-$860.000 million vs $822.049 million estimate.

Benzinga Newsdesk

PRO
Hinge Health Sees Q3 Sales $223.000M-$225.000M vs $211.004M Est

Hinge Health (NYSE:HNGE) sees Q3 sales of $223.000 million-$225.000 million vs $211.004 million analyst estimate.

Benzinga Newsdesk

PRO
Hinge Health Q2 Adj. EPS $0.59, Inline, Sales $212.817M Beat $201.030M Estimate

Hinge Health (NYSE:HNGE) reported quarterly earnings of $0.59 per share which met the analyst consensus estimate. This is a 13.24 percent decrease over earnings of $0.68 per share from the same period last year. The

Benzinga Newsdesk

PRO
Hinge Health Raises FY2026 Sales Guidance from $732.000M-$742.000M to $798.000M-$804.000M vs $735.921M Est

Hinge Health (NYSE:HNGE) raises FY2026 sales outlook from $732.000 million-$742.000 million to $798.000 million-$804.000 million vs $735.921 million estimate.

Benzinga Newsdesk

PRO
Hinge Health Sees Q2 Sales $194.000M-$196.000M vs $179.019M Est

Hinge Health (NYSE:HNGE) sees Q2 sales of $194.000 million-$196.000 million vs $179.019 million analyst estimate.

Benzinga Newsdesk

PRO
Hinge Health Q1 Adj. EPS $0.45 Beats $0.38 Estimate, Sales $182.307M Beat $172.164M Estimate

Hinge Health (NYSE:HNGE) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.38 by 18.42 percent. The company reported quarterly sales of $182.307 million which beat the

Benzinga Newsdesk

Hinge Health Inc